ClinicalTrials.Veeva

Menu

5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma (HACAMI)

I

Institut de Cancérologie de Lorraine

Status

Completed

Conditions

Breast Cancer

Treatments

Other: questionnary of quality of life

Study type

Observational

Funder types

Other

Identifiers

NCT02791750
ICL OBS 02

Details and patient eligibility

About

Non-persistence to adjuvant hormonal therapy for breast cancer at 5 years decrease its efficacy. The objective of this study is to know the women experience (persistence, treatment changes, quality of life) and its determinants, in a french population.

Enrollment

150 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients following-up in the Lorraine Institute of Oncology at 5 years of the beginning of an adjuvant hormonal therapy
  • Women with breast invasive carcinoma positive-RH and indication of adjuvant hormonal therapy
  • Adult patients
  • Being capable and agree to follow the study procedure
  • Patients informed and non-opposed
  • Covered by social security

Exclusion criteria

  • History of other cancer except basal cell carcinoma
  • Patients with breast invasive carcinoma negative-RH
  • Synchronous metastases
  • Relapsed
  • Previous adjuvant hormonal therapy
  • Men
  • Patients with guardianship

Trial design

150 participants in 1 patient group

Observational
Description:
Patients followed for a medical consultation in the Institut de Cancérologie de Lorraine at 5 years of the beginning of an adjuvant hormonal therapy.
Treatment:
Other: questionnary of quality of life

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems